KNect365 is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Former EMA boss Lönngren proposes hard Brexit solution

Pharma is clearly worried about how the UK's exit from the EU will disrupt both the EMA's capacity for drugs reviews and the pan-European regulatory environment. Former EMA executive director Thomas Lönngren explained to Scrip during the BIO-Europe Spring meeting that the relationship between EMA and FDA could be a model the UK's MHRA could adopt if the British take a hard Brexit route.

Get the latest news as it happens.